Delivery Order SPE2DB22D1041-SPE2DB25FUCF9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,054.44 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product, on March 12, 2025, with completion expected by March 13, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside status and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,401.50 to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no...
- The Defense Logistics Agency awarded a $2,069.16 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 MG in 30-count packaging. The contract, which is non-set-aside and competitively awarded on a firm fixed price basis, is scheduled for completion by August 5, 2025, with performance to occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- This delivery order, awarded June 3, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, represents a firm fixed-price pharmaceutical supply contract valued at $2,975.18. The order calls for delivery of AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-tablet supply to the vendor's location in Conshohocken, Pennsylvania, with completion scheduled for June 4, 2025. The contract was awarded without set-aside designation through competitive procurement, reflecting AmerisourceBergen's...
- This delivery order, valued at $1,328.82, was awarded on July 31, 2025, to AmerisourceBergen Drug Corp for the supply of AMLOD-VALSA-HCTZ 10-160-12.5MG medication in 30-unit quantities. The contract is funded by the Defense Logistics Agency's Medical Supply Chain and executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This award is structured as a firm fixed-price delivery order with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,703.95 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-320 mg tablets (30-count units) on August 22, 2025, with completion targeted for August 25, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $5,397.13 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-12.5 mg tablets (90-count supply) on September 24, 2025, with completion scheduled for September 25, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $7,659.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561376943 AMLOD-VALSA-HCTZ 10-160-25 MG 30S. The place of performance will be Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The delivery order has a period of performance from June 29, 2023 through June 30, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this award will help the Defense...
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, valued at $1,812.56, for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count supply) with an ultimate completion date of August 27, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUCF9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,948.80 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products, with an ultimate completion date of September 23, 2025. This firm fixed-price, non-set-aside contract was awarded on September 22, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this medical supply requirement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order represents a single transaction within this strategic contract vehicle that supports federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 9/22/25 |